CD45 isoform expression in autoimmune myasthenia gravis

Area of Science:

• Immunology
• Genetics
• Neurology

Background:

• Myasthenia gravis (MG) involves complex immune system dysregulation.
• The CD45 molecule (protein-tyrosine phosphatase receptor type C, PTPRC) plays a critical role in T and B cell function.
• Previous research suggested a CD45 association in multiple sclerosis.

Purpose of the Study:

• To investigate the role of the CD45 molecule in myasthenia gravis pathogenesis.
• To determine the prevalence of a specific CD45 gene mutation (exon 4 77C --> G) in MG patients.
• To analyze the distribution of naive (CD45RA+) and memory (CD45RO+) T cells in MG patients' peripheral blood.

Main Methods:

• Flow cytometry was used to quantify CD45RA+ and CD45RO+ T cells in 78 generalized MG patients and 67 age/sex-matched controls.
• Prevalence analysis of the CD45 gene mutation involved 78 MG patients and 303 healthy individuals.
• Statistical analyses included Fisher's exact test, chi-squared test, Mann-Whitney test, and Spearman's correlation.

Main Results:

• The 77C --> G mutation in CD45 exon 4 was found in one MG patient but not in 303 controls, indicating no overall association.
• A significantly lower ratio of CD45RO+ to CD45RA+ T cells was observed in CD8+ T cells of late-onset MG patients (P = 0.023).
• A similar trend was noted in CD4+ and CD8+ T cells of thymoma patients, independent of treatment or thymectomy.

Conclusions:

• The specific CD45 gene mutation studied is not associated with myasthenia gravis.
• Late-onset MG patients exhibit an altered balance of circulating T cell subsets.
• This altered subset distribution may reflect a distinct immunological profile in late-onset MG, potentially independent of thymopoiesis.